Teva Pharmaceutical Indus (NYSE:TEVA) 公佈了第四季度每股收益爲$0.71，高於分析師普遍預期的$0.70，超出1.43個百分點。與去年同期每股收益$1.00相比下降了29%。公司報告季度銷售額爲42億美元，高於分析師普遍預期的41.3億美元，超出1.69個百分點。與去年同期銷售額44.6億美元相比下降了5.77%。

以上內容來自Benzinga Earnings專欄，原文如下：

Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.70 by 1.43 percent. This is a 29 percent decrease over earnings of $1.00 per share from the same period last year. The company reported quarterly sales of $4.20 billion which beat the analyst consensus estimate of $4.13 billion by 1.69 percent. This is a 5.77 percent decrease over sales of $4.46 billion the same period last year.